Zerviate For Solution
Product Images NDC 82667-015

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Zerviate (NDC 82667-015). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Harrow Eye, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zer00 0000 01)

Chemical Structure (Zer00 0000 01)
Chemical structure diagram of cetirizine dihydrochloride, the active ingredient in ZERVIATE ophthalmic solution 2.4 mg/mL by Harrow Eye, LLC. The image depicts the molecular arrangement of the cetirizine compound with associated hydrochloride groups.*
FDA Label Image

Figure (Zer00 0000 02)

Figure (Zer00 0000 02)
Packaging label for ZERVIATE (cetirizine ophthalmic solution) 0.24%, an ophthalmic solution in 0.2 mL single-use containers. The label indicates 30 single-use containers packaged as 6 pouches of 5 containers each. The product is for topical ophthalmic use, Rx only, sterile, and is labeled by Harrow Eye, LLC. The label includes active ingredient information and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.